Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles by Staff

Cellular Therapy of Autoimmune Disease

Alan Tyndall, MD  |  November 1, 2008

Is a novel treatment breakthrough on the horizon?

Medical Decision Making and Coding

Melesia Tillman, CPC, CCP  |  October 1, 2008

In my years of coding for rheumatology, I am often asked this type of question: “I have a patient who recently came in for a visit. She had two or three diagnoses, was placed on three or four different medications, and we ran one or two labs on her. Does this qualify for a level-four visit?”

I Am an Advocate

Charles King, MD  |  October 1, 2008

It was the best of times, it was the worst of times; it was the age of wisdom, it was the age of foolishness.” Cliché perhaps, but certainly fitting in describing the practice of rheumatology of late. We have been blessed with a widening array of therapies with which to treat rheumatologic illnesses. The advent of the biological era promises even greater potential for meaningful reductions in disability and death from these diseases.

An American in Paris

David S. Pisetsky, MD, PhD  |  October 1, 2008

Visiting a historical city inspires reflections on the history and progress of rheumatology

A Workforce for the Future

David A. Fox, MD  |  October 1, 2008

The ACR is working hard to meet tomorrow’s needs

Rheum to Learn

Terry Hartnett  |  October 1, 2008

The ARHP’s new NP/PA rheumatology training program will provide a boost to the workforce

Wegener’s Granulomatosis Treatment Today

Carol A. Langford, MD MHS  |  October 1, 2008

WG has an evolving prognosis and treatment course

The Quest for Olympic Gold

David S. Pisetsky, MD, PhD  |  September 1, 2008

What should physicians make of sick athletes’ success stories?

Get Involved!

David A. Fox, MD  |  September 1, 2008

A guide for applying to volunteer positions with the ACR

The Brain in Lupus

Michael Lockshin, MD, and Liza Kozora, PhD  |  September 1, 2008

The Mary Kirkland Center lupus conference offers insight into cognitive aspects of SLE

  • « Previous Page
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 150
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences